William F. Owen
Directeur/Membre du Conseil chez Association of Academic Health Centers
Profil
Dr. William F.
Owen, Jr. MD, is a Director at New Jersey Health Foundation, Inc. He is on the Board of Directors at Association of Academic Health Centers and Savient Pharmaceuticals, Inc.
Dr. Owen received his undergraduate degree from Brown University and a doctorate degree from Tufts University.
Postes actifs de William F. Owen
| Sociétés | Poste | Début |
|---|---|---|
Association of Academic Health Centers
 Association of Academic Health Centers Miscellaneous Commercial ServicesCommercial Services Part of The Association of American Medical Colleges, Association of Academic Health Centers is a medical education, research, and healthcare organization based in Washington. The American company's mission is to provide tomorrow's doctors with tomorrow's cures. The company offers resources and updates for the AAMC community on the coronavirus pandemic. The company was founded in 1980, and Steven L. Kanter has been the CEO of the company since 2018. The company was acquired by The Association of American Medical Colleges on April 01, 2022. | Directeur/Membre du Conseil | 28/09/2010 |
| Ross University School of Medicine | Corporate Officer/Principal | 01/03/2017 |
Anciens postes connus de William F. Owen
| Sociétés | Poste | Fin |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Directeur/Membre du Conseil | 07/01/2013 |
| New Jersey Health Foundation, Inc. | Corporate Officer/Principal | - |
Formation de William F. Owen
| Tufts University | Doctorate Degree |
| Brown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Association of Academic Health Centers
Association of Academic Health Centers Miscellaneous Commercial ServicesCommercial Services Part of The Association of American Medical Colleges, Association of Academic Health Centers is a medical education, research, and healthcare organization based in Washington. The American company's mission is to provide tomorrow's doctors with tomorrow's cures. The company offers resources and updates for the AAMC community on the coronavirus pandemic. The company was founded in 1980, and Steven L. Kanter has been the CEO of the company since 2018. The company was acquired by The Association of American Medical Colleges on April 01, 2022. | Commercial Services |
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
| New Jersey Health Foundation, Inc. | Finance |